Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Greenwich LifeSciences Inc.
Sponsor

Greenwich LifeSciences Inc.

United States 2311 Spartan Trail, 77479-3341, United States

About the sponsor

Greenwich LifeSciences Inc. focuses on HER2/neu-positive breast cancer, with research centered on patients at elevated risk of recurrence after standard trastuzumab-based treatment.

  • HER2/neu-targeted therapy
  • Recurrence-risk reduction
  • Adjuvant cancer treatment

The sponsor’s clinical activity is concentrated on immunologically directed approaches for patients with residual disease or high-risk pathological response features in early-stage and locally advanced breast cancer.

About Specializations

Greenwich LifeSciences Inc. runs clinical trials in conditions such as Breast cancer, HER2 positive breast cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Breast cancer+1

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Sargramostim
  • Sponsor:Greenwich LifeSciences Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.